October 06, 2014
Bernstein Liebhard LLP is investigating whether the Board of Directors of CareFusion Corporation (“CareFusion” or the “Company”) (NYSE: CFN) breached its fiduciary duty to its shareholders in agreeing to sell CareFusion to Becton, Dickinson and Company (“BD”).
Under the terms of the agreement, CareFusion shareholders will receive $49.00 in cash and 0.0777 of a share of BD for each share they own. The investigation is focused on the potential unfairness of the price to CareFusion shareholders and the process by which the CareFusion Board of Directors considered and approved the transaction.
If you are interested in discussing your rights as a CareFusion stockholder, with no obligation or cost to you, please contact U. Seth Ottensoser at (877) 779-1414 or Ottensoser@bernlieb.com.
Bernstein Liebhard LLP has pursued hundreds of securities, consumer and shareholder rights cases and recovered over $3 billion for its clients. It has been named to The National Law Journal’s “Plaintiffs’ Hot List” in each of the last twelve years.